On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Jabil Inc. JBL, adding that it is “such a good company.”
On Sept. 26, Jabil reported better-than-expected fourth-quarter financial results and approved a $1 billion share buyback. Jabil reported fourth-quarter revenue of $6.96 billion, down by 17.7% year-on-year, beating the analyst consensus estimate of $6.59 billion. The print manufacturing company’s adjusted EPS of $2.30 beat the analyst consensus estimate of $2.22.
When asked about MeiraGTx Holdings plc MGTX, he said, “Put it away, speculate. If something great happens, terrific. If not, you won't even notice.”
On Oct. 15, MeiraGTx released topline data from its clinical bridging study of AAV-GAD for Parkinson's disease, MGT-GAD-025. MGT-GAD-025 is a 6-month, three-arm, randomized, double-blind, sham-controlled study using AAV-GAD drug product manufactured by MeiraGTx at its wholly-owned facilities with its commercial platform process.
SoFi Technologies, Inc. SOFI is good, Cramer said.
On Oct. 29, SoFi reported third-quarter adjusted sales of $689.445 million, beating analyst estimates of $632.328 million, according to Benzinga Pro.
The company reported third-quarter earnings of 5 cents per share, beating estimates of 4 cents per share. SoFi raised its full-year revenue forecast from a range of $2.425 billion to $2.465 billion to a new range of $2.535 billion to $2.55 billion versus estimates of $2.45 billion, according to Benzinga Pro.
Price Action:
- MeiraGTx shares gained 4.8% to settle at $6.73 on Thursday.
- Jabil shares fell 0.3% to close at $137.30 on Thursday.
- SoFi shares gained 0.8% to settle at $11.90 during the session.
Read Next:
Image: Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.